Results from a phase III trial Proton Therapy in Head and Neck Cancer

A groundbreaking multi-institution Phase III trial led by The University of Texas MD Anderson Cancer Center reveals that intensity modulated proton therapy (IMPT) provides significant benefits for patients with oropharyngeal cancer. Compared to traditional intensity modulated radiation therapy (IMRT), IMPT showed similar progression-free survival rates but significantly reduced malnutrition and feeding-tube dependence. With a median […]

Data privacy

The protection of your personal data is important to us, and we aim to comply with the requirements ofthe Personal Data Protection Act 2012 (“PDPA”) in respect of the collection, use and disclosure of your personaldata. Please read the our Data Protection Notice for information on how we manage your personal data. If you have any enquiries regarding the our […]

nasopnaryngeal carcinoma radiotherapy dose
Nasopharyngeal carcinoma and radiotherapy Radiotherapy techniques Radiotherapy is a very effective treatment for NPC. In early-stage NPC, the cure rate is over 90%. Even in more advanced stages, radiotherapy can shrink the tumor and improve symptoms. The cure rates from a large Chinese cohort study showed that even in patients with lower-staged cancers have a progression-free probability of […]